Feng Tian

Health Technology

Consumer Services

Profile

Feng Tian is the founder of LuxVitae Therapeutics, Inc. Prior to that, he served as Chairman, President & CEO of Ambrx, Inc. and Ambrx Biopharma Cayman, Inc. He received his undergraduate degree from Peking University and his doctorate from the University of Florida.

Former positions of Feng Tian

Companies	Position	End
Ambrx Biopharma, Inc. Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA.	Chief Executive Officer	2022-08-14
LuxVitae Therapeutics, Inc.	Founder	-
AMBRX INC	Chief Executive Officer	-

See the detail of Feng Tian's experience

Training of Feng Tian

University of Florida	Doctorate Degree
Peking University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Feng Tian's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Ambrx, Inc. Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA.	Health Technology
Ambrx Biopharma, Inc. Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA.	Health Technology
LuxVitae Therapeutics, Inc.

See company connections